MYGN

MYRIAD GENETICS INC

Biotechnology · Biotechnology

$276.44 sample

-0.63 (-0.23%) 1D

Market cap

$752.6B

Price as of

2026-10-04

Latest filing

8-K · 2026-08-13

Alerts

8

Price$276.44 +13.32% 3M daily closessample

279.18241.26

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider buy: 10% owner
Sep 17INSInsider sell: Director
Sep 11INSInsider sell: General Counsel
Sep 04INSInsider sell: EVP, Operations
Aug 26INSInsider sell: EVP, Operations
Aug 19INSInsider buy: General Counsel
Aug 13SECDEF 14A filed
Aug 10INSInsider buy: General Counsel

Sign up to see the real MYGN record →

Company facts

SEC EDGAR registration

Name: MYRIAD GENETICS INC
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -24sample, -100 to +100
Reporting currency: USD

Who is positioning in MYGN

sample

Insiders: 6 insider transactions over 90 days, net selling, $536.3M
Congress: No member trades over 90 days
Institutions · 13F: 12 funds hold $12.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$45.5B +12.9% y/y

Q4 2024Q3 2026

Inventory$26.2B +6.3% y/y

Q4 2024Q3 2026

Accounts receivable$19.9B +10.8% y/y

Q4 2024Q3 2026

Total debt$55.3B +17.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $720.9B -3.1% 3M
Sample peer B: $281.0B +10.8% 3M
Sample peer C: $96.5B -0.7% 3M
Sample peer D: $168.0B -8.0% 3M
Sample peer E: $727.8B +2.7% 3M